The Food and Drug Administration has requested comments on a proposed experimental study titled "Effect of Promotional Offers in Direct-to-Consumer Prescription Drug Print Advertisements on Consumer Product Perceptions."
Based on prior research that shows that the type of promotion offered can affect how consumers respond, the FDA plans to study the use of consumer-oriented sales promotions such as free trial offers, discounts, money-back guarantees, rebates, and sweepstakes. The study will examine the type of promotional offer in three types of drug advertisements (prescription drug reminder ad, prescription drug full product ad, and OTC drug ad), in a “medium prevalence” medical condition.
The Federal Register Notice can be found here. Comments are due November 22, 2010.